SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-173791
Filing Date
2011-06-27
Accepted
2011-06-27 08:08:37
Documents
11
Period of Report
2011-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.htm 8-K 49822
2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION dex21.htm EX-2.1 732407
3 LETTER AGREEMENT: RONALD MARTEL dex103.htm EX-10.3 12771
4 LETTER AGREEMENT: MICHAEL S. PERRY dex104.htm EX-10.4 8712
5 LETTER AGREEMENT: MICHAEL K. JACKSON dex105.htm EX-10.5 6276
6 LETTER AGREEMENT: CHENI KWOK dex106.htm EX-10.6 8900
7 LETTER AGREEMENT: ANNA L. WIGHT dex107.htm EX-10.7 8744
8 PRESS RELEASE dex991.htm EX-99.1 25074
9 GRAPHIC g200628g56g25.jpg GRAPHIC 7856
10 GRAPHIC g200628g67q84.jpg GRAPHIC 5347
11 GRAPHIC g200628g68t67.jpg GRAPHIC 8737
  Complete submission text file 0001193125-11-173791.txt   884819
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 11931864
SIC: 2834 Pharmaceutical Preparations